InvestorsHub Logo

lennie

03/13/18 11:36 AM

#277 RE: jrf30 #276

I think the sell off is a knee jerk reaction due to discontinuing there Yosprala drug. The increase in the quarterly loss was the right off of the fair value of Yosprala. Otherwise, we might have missed the projected loss by only .03. Next quarter should be much better. JMHO